341 related articles for article (PubMed ID: 12200791)
1. The new liver allocation system: moving toward evidence-based transplantation policy.
Freeman RB; Wiesner RH; Harper A; McDiarmid SV; Lake J; Edwards E; Merion R; Wolfe R; Turcotte J; Teperman L;
Liver Transpl; 2002 Sep; 8(9):851-8. PubMed ID: 12200791
[TBL] [Abstract][Full Text] [Related]
2. Results of the first year of the new liver allocation plan.
Freeman RB; Wiesner RH; Edwards E; Harper A; Merion R; Wolfe R;
Liver Transpl; 2004 Jan; 10(1):7-15. PubMed ID: 14755772
[TBL] [Abstract][Full Text] [Related]
3. Is MELD really the definitive score for liver allocation?
Lladó L; Figueras J; Memba R; Xiol X; Baliellas C; Vázquez S; Ramos E; Torras J; Rafecas A; Fabregat J; Lama C; Jaurrieta E
Liver Transpl; 2002 Sep; 8(9):795-8. PubMed ID: 12200780
[TBL] [Abstract][Full Text] [Related]
4. Model for end-stage liver disease: impact of the new deceased donor liver allocation policy in São Paulo, Brazil.
Monteiro F; Coria SA; Boni R; Pereira LA
Transplant Proc; 2009; 41(1):226-8. PubMed ID: 19249520
[TBL] [Abstract][Full Text] [Related]
5. Overview of the MELD score and the UNOS adult liver allocation system.
Martin AP; Bartels M; Hauss J; Fangmann J
Transplant Proc; 2007 Dec; 39(10):3169-74. PubMed ID: 18089345
[TBL] [Abstract][Full Text] [Related]
6. Application of a continuous disease severity score to the OPTN liver waiting list.
Edwards EB; Harper AM
Clin Transpl; 2001; ():19-24. PubMed ID: 12211782
[TBL] [Abstract][Full Text] [Related]
7. Model for end-stage liver disease: did the new liver allocation policy affect waiting list mortality?
Austin MT; Poulose BK; Ray WA; Arbogast PG; Feurer ID; Pinson CW
Arch Surg; 2007 Nov; 142(11):1079-85. PubMed ID: 18025337
[TBL] [Abstract][Full Text] [Related]
8. Liver transplantation for hepatocellular carcinoma: the MELD impact.
Sharma P; Balan V; Hernandez JL; Harper AM; Edwards EB; Rodriguez-Luna H; Byrne T; Vargas HE; Mulligan D; Rakela J; Wiesner RH
Liver Transpl; 2004 Jan; 10(1):36-41. PubMed ID: 14755775
[TBL] [Abstract][Full Text] [Related]
9. Survival on waiting list for liver transplantation before and after introduction of the model for end-stage liver disease score.
Tenório AL; Macedo FI; Miranda LE; Fernandes JL; da Silva CM; Neto OL; Lacerda CM
Transplant Proc; 2010 Mar; 42(2):407-11. PubMed ID: 20304152
[TBL] [Abstract][Full Text] [Related]
10. New national liver transplant allocation policy: is the regional review board process fair?
Voigt MD; Zimmerman B; Katz DA; Rayhill SC
Liver Transpl; 2004 May; 10(5):666-74. PubMed ID: 15108259
[TBL] [Abstract][Full Text] [Related]
11. The pediatric end-stage liver disease (PELD) model as a predictor of survival benefit and posttransplant survival in pediatric liver transplant recipients.
Barshes NR; Lee TC; Udell IW; O'mahoney CA; Karpen SJ; Carter BA; Goss JA
Liver Transpl; 2006 Mar; 12(3):475-80. PubMed ID: 16498644
[TBL] [Abstract][Full Text] [Related]
12. National and regional analysis of exceptions to the Pediatric End-Stage Liver Disease scoring system (2003-2004).
Shneider BL; Suchy FJ; Emre S
Liver Transpl; 2006 Jan; 12(1):40-5. PubMed ID: 16382460
[TBL] [Abstract][Full Text] [Related]
13. Model for end-stage liver disease (MELD) and allocation of donor livers.
Wiesner R; Edwards E; Freeman R; Harper A; Kim R; Kamath P; Kremers W; Lake J; Howard T; Merion RM; Wolfe RA; Krom R;
Gastroenterology; 2003 Jan; 124(1):91-6. PubMed ID: 12512033
[TBL] [Abstract][Full Text] [Related]
14. MELD-based liver allocation: who is underserved?
Biggins SW; Bambha K
Semin Liver Dis; 2006 Aug; 26(3):211-20. PubMed ID: 16850370
[TBL] [Abstract][Full Text] [Related]
15. Model for end-stage liver disease exceptions in the context of the French model for end-stage liver disease score-based liver allocation system.
Francoz C; Belghiti J; Castaing D; Chazouillères O; Duclos-Vallée JC; Duvoux C; Lerut J; Le Treut YP; Moreau R; Mandot A; Pageaux G; Samuel D; Thabut D; Valla D; Durand F
Liver Transpl; 2011 Oct; 17(10):1137-51. PubMed ID: 21695771
[TBL] [Abstract][Full Text] [Related]
16. Is MELD score sufficient to predict not only death on waiting list, but also post-transplant survival?
Silberhumer GR; Hetz H; Rasoul-Rockenschaub S; Peck-Radosavljevic M; Soliman T; Steininger R; Muehlbacher F; Berlakovich GA
Transpl Int; 2006 Apr; 19(4):275-81. PubMed ID: 16573542
[TBL] [Abstract][Full Text] [Related]
17. Model for End-Stage Liver Disease (MELD) score and organ allocation from cadaveric donors for 198 liver transplantation procedures performed in a single center.
Santori G; Andorno E; Morelli N; Casaccia M; Bottino G; Ghirelli R; Valente U
Transplant Proc; 2008; 40(6):1903-5. PubMed ID: 18675084
[TBL] [Abstract][Full Text] [Related]
18. The sickest first? Disparities with model for end-stage liver disease-based organ allocation: one region's experience.
Schaffer RL; Kulkarni S; Harper A; Millis JM; Cronin DC
Liver Transpl; 2003 Nov; 9(11):1211-5. PubMed ID: 14586883
[TBL] [Abstract][Full Text] [Related]
19. The impact of MELD on OPTN liver allocation: preliminary results.
Edwards EB; Harper AM
Clin Transpl; 2002; ():21-8. PubMed ID: 12971434
[TBL] [Abstract][Full Text] [Related]
20. The MELD score in patients awaiting liver transplant: strengths and weaknesses.
Bernardi M; Gitto S; Biselli M
J Hepatol; 2011 Jun; 54(6):1297-306. PubMed ID: 21145851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
